Related references
Note: Only part of the references are listed.Chlordane exposure causes developmental delay and metabolic disorders in Drosophila melanogaster
Qifang Wu et al.
ECOTOXICOLOGY AND ENVIRONMENTAL SAFETY (2021)
Developmental Toxicology of Metal Mixtures in Drosophila: Unique Properties of Potency and Interactions of Mercury Isoforms
Catherine R. Beamish et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Drosophila melanogaster a Versatile Model of Parkinson's Disease
Falaq Naz et al.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2021)
Effect of alloxan on the third instar larvae of transgenic Drosophila melanogaster (hsp70-lacZ)Bg9
Yasir Hasan Siddique et al.
TOXIN REVIEWS (2020)
Toxicological Study and Genetic Basis of BTEX Susceptibility in Drosophila melanogaster
Temitope H. Adebambo et al.
FRONTIERS IN GENETICS (2020)
Metabolic activation and toxicological evaluation of polychlorinated biphenyls in Drosophila melanogaster
T. Idda et al.
SCIENTIFIC REPORTS (2020)
Effect of ethylparaben on the growth and development of Drosophila melanogaster on preadult
Lin Gao et al.
ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY (2020)
Drosophila melanogaster as a powerful tool for studying insect toxicology
Jeffrey G. Scott et al.
PESTICIDE BIOCHEMISTRY AND PHYSIOLOGY (2019)
Toxicological effects of ciprofloxacin exposure to Drosophila melanogaster
Jinyue Liu et al.
CHEMOSPHERE (2019)
A drosophila model for toxicogenomics: Genetic variation in susceptibility to heavy metal exposure
Shanshan Zhou et al.
PLOS GENETICS (2017)
Drosophila melanogaster a potential model organism for identification of pharmacological properties of plants/plant-derived components
Komal Panchal et al.
BIOMEDICINE & PHARMACOTHERAPY (2017)
In Vivo Toxicity Evaluation of Graphene Oxide in Drosophila Melanogaster After Oral Administration
Haiyan Zou et al.
JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY (2016)
Toxic potential of copper-doped ZnO nanoparticles in Drosophila melanogaster (Oregon R)
Yasir Hasan Siddique et al.
TOXICOLOGY MECHANISMS AND METHODS (2015)
Toxic potential of copper-doped ZnO nanoparticles in Drosophila melanogaster (Oregon R)
Yasir Hasan Siddique et al.
TOXICOLOGY MECHANISMS AND METHODS (2015)
Study of the changes in life cycle parameters of Drosophila melanogaster exposed to fluorinated insecticide, cryolite
Sayanti Podder et al.
TOXICOLOGY AND INDUSTRIAL HEALTH (2015)
Dissecting the Insect Metabolic Machinery Using Twin Ion Mass Spectrometry: A Single P450 Enzyme Metabolizing the Insecticide Imidacloprid in Vivo
Kin Kuan Hoi et al.
ANALYTICAL CHEMISTRY (2014)
Toxic Potential of Synthesized Graphene Zinc Oxide Nanocomposite in the Third Instar Larvae of Transgenic Drosophila melanogaster (hsp70-lacZ)Bg9
Yasir Hasan Siddique et al.
BIOMED RESEARCH INTERNATIONAL (2014)
Evaluation of the Toxic Potential of Graphene Copper Nanocomposite (GCNC) in the Third Instar Larvae of Transgenic Drosophila melanogaster (hsp70-lacZ)Bg9
Yasir Hasan Siddique et al.
PLOS ONE (2013)
Exendin-4 reduces glycemia by increasing liver glucokinase activity: an insulin independent effect
Nirav Dhanesha et al.
PHARMACOLOGICAL REPORTS (2012)
Drosophotoxicology: The growing potential for Drosophila in neurotoxicology
Matthew D. Rand
NEUROTOXICOLOGY AND TERATOLOGY (2010)
Metabolism of imidacloprid and DDT by P450 GYP6G1 expressed in cell cultures of Nicotiana tabacum suggests detoxification of these insecticides in Cyp6g1-overexpressing strains of Drosophila melanogaster, leading to resistance
Nicole Joussen et al.
PEST MANAGEMENT SCIENCE (2008)
Effect of different heavy-metal concentrations on Drosophila melanogaster larval growth and development
FA Al-Momani et al.
BIOLOGICAL TRACE ELEMENT RESEARCH (2005)
Induction of hsp70 in transgenic Drosophila:: biomarker of exposure against phthalimide group of chemicals
A Nazir et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2003)
Evaluation of the no observed adverse effect level of solvent dimethyl sulfoxide in Drosophila melanogaster
A Nazir et al.
TOXICOLOGY MECHANISMS AND METHODS (2003)
Effects of pharmacological agents upon a transgenic model of Parkinson's disease in Drosophila melanogaster
RG Pendleton et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)